In Vivo Study of the Effects of ERβ on Apoptosis and Proliferation of Hormone-Independent Prostate Cancer Cell Lines PC-3M

BioMed Research International
Changli ZhouFeng Li

Abstract

To evaluate the in vivo therapeutic effects of attenuated Salmonella carrying PCDNA3.1-ERβ plasmid in hormone-independent prostatic cancer in nude mice and to clarify the mechanism by which estrogen receptor β (ERβ) induces apoptosis and proliferation in prostatic cancer cells in mice. The orthotopic prostatic cancer models of mice were randomly divided as follows: MOCK group, treated with PBS, PQ group, treated with attenuated Salmonella alone, PQ-PCDNA3.1 group, treated with attenuated Salmonella carrying PCDNA3.1 plasmid, and PQ-PCDNA3.1-ERβ group, treated with the attenuated Salmonella carrying PCDNA3.1-ERβ plasmid. Then, 10 μl of the plasmid-containing solution, comprising 1 × 107 cfu of the bacteria, was administered via intranasal delivery to each group except the MOCK group. The experimental methods included flow cytometry and terminal deoxyribonucleotidyl transferase-mediated dUTP-digoxigenin nick end-labelling (TUNEL) assay, immunohistochemistry, and western blotting. Compared with the MOCK, PQ, and PQ-PCDNA3.1 groups, the weights of tumors in the PQ-PCDNA3.1-ERβ group were significantly reduced. The results of flow cytometry and TUNEL assay revealed that the number of apoptotic cells in the PQ-PCDNA3.1-ERβ group sign...Continue Reading

References

Jul 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·S I MillerJ J Mekalanos
Jun 11, 1996·Proceedings of the National Academy of Sciences of the United States of America·G G KuiperJ A Gustafsson
Jan 1, 1996·Annual Review of Neuroscience·R A Segal, M E Greenberg
Jan 1, 1996·European Urology·L PylkkänenR Santti
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·J H KregeO Smithies
Jul 1, 1999·The Prostate·W Y Chang, G S Prins
Aug 6, 1999·The American Journal of Pathology·H BonkhoffK Remberger
Dec 2, 1999·Genes & Development·S R DattaM E Greenberg
Mar 8, 2000·Proceedings of the National Academy of Sciences of the United States of America·G PoelzlM E Mendelsohn
Apr 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·R XiangR A Reisfeld
Oct 26, 2000·Nature·M O Hengartner
Nov 10, 2000·International Journal of Cancer. Journal International Du Cancer·K IwaoS Noguchi
Jun 19, 2001·Molecular and Cellular Endocrinology·D PasqualiA A Sinisi
Jul 5, 2001·The American Journal of Pathology·S Signoretti, M Loda
Aug 23, 2001·Endocrinology·G LazennecF Vignon
Sep 5, 2001·The Journal of Biological Chemistry·B S FinlinC M Perou
Dec 18, 2001·International Journal of Cancer. Journal International Du Cancer·L YuhuaR Daming
Mar 8, 2002·Cellular Signalling·Karleen M Nicholson, Neil G Anderson
Apr 12, 2002·Trends in Endocrinology and Metabolism : TEM·Renea A JarredGail P Risbridger
Aug 6, 2002·Molecular and Cellular Endocrinology·Zhang WeihuaJan-Ake Gustafsson
Oct 9, 2002·Proceedings of the National Academy of Sciences of the United States of America·Zhang WeihuaJan-Ake Gustafsson
Feb 21, 2004·CA: a Cancer Journal for Clinicians·Ahmedin JemalUNKNOWN American Cancer Society
Mar 5, 2004·Biochimica Et Biophysica Acta·Vladimir KirkinMartin Zörnig
Sep 17, 2004·Endocrine-related Cancer·A BardinP Pujol
Nov 17, 2005·BJU International·Géraldine Cancel-Tassin, Olivier Cussenot
Oct 24, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jes DietrichPeter Andersen
Dec 7, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·William A RickeGail P Risbridger
Jan 29, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ling ZhangDe-Qi Xu
Jun 19, 2008·Differentiation; Research in Biological Diversity·Stephen J McPhersonGail P Risbridger
Dec 17, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ton van AgthovenLambert C J Dorssers
Jan 14, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Yousif O Al-BazzPauline R M Dobson

❮ Previous
Next ❯

Citations

Sep 16, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jessica BordiniAlessandro Campanella

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
electrophoresis
flow cytometry
FACS
Infrared Imaging
transfecting

Software Mentioned

FACS
Quantity One

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.